109 related articles for article (PubMed ID: 20960887)
1. [A novel cardiovascular marker: pentraxin 3].
Inoue K
Nihon Rinsho; 2010 Jul; 68 Suppl 7():862-5. PubMed ID: 20960887
[No Abstract] [Full Text] [Related]
2. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction.
Matsubara J; Sugiyama S; Nozaki T; Sugamura K; Konishi M; Ohba K; Matsuzawa Y; Akiyama E; Yamamoto E; Sakamoto K; Nagayoshi Y; Kaikita K; Sumida H; Kim-Mitsuyama S; Ogawa H
J Am Coll Cardiol; 2011 Feb; 57(7):861-9. PubMed ID: 21310324
[TBL] [Abstract][Full Text] [Related]
3. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
Clin J Am Soc Nephrol; 2007 Sep; 2(5):889-97. PubMed ID: 17702732
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma pentraxin 3: a potential cardiovascular risk factor?
Liu Q; Tu T; Bai Z; Liu Z; Zhou S
Med Hypotheses; 2011 Dec; 77(6):1068-70. PubMed ID: 21944885
[TBL] [Abstract][Full Text] [Related]
5. Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level.
Ctirad A; Lenka B; David P; Zdenek F; Kveta H; Karel E; Jan K
Int J Dermatol; 2008 Oct; 47(10):1011-4. PubMed ID: 18986345
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed immunoassay: quantitation and profiling of serum biomarkers using magnetic nanoprobes and MALDI-TOF MS.
Wang KY; Chuang SA; Lin PC; Huang LS; Chen SH; Ouarda S; Pan WH; Lee PY; Lin CC; Chen YJ
Anal Chem; 2008 Aug; 80(16):6159-67. PubMed ID: 18642877
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections.
Mairuhu AT; Peri G; Setiati TE; Hack CE; Koraka P; Soemantri A; Osterhaus AD; Brandjes DP; van der Meer JW; Mantovani A; van Gorp EC
J Med Virol; 2005 Aug; 76(4):547-52. PubMed ID: 15977234
[TBL] [Abstract][Full Text] [Related]
8. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
9. Increased serum pentraxin 3 in patients with systemic sclerosis.
Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
[TBL] [Abstract][Full Text] [Related]
10. [The revival of an old diagnostic marker: C-reactive protein].
Sela B
Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
[No Abstract] [Full Text] [Related]
11. [CRP level as risk marker of cardiovascular disease?].
Thelle DS; Arnesen E
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):512-4. PubMed ID: 20224622
[No Abstract] [Full Text] [Related]
12. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
Biasucci LM
Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
[No Abstract] [Full Text] [Related]
13. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
14. [Possible association between serum C-reactive protein concentrations and ischemic heart disease].
Shapira I; Zeltzer D; Berliner S
Harefuah; 1999 Aug; 137(3-4):149-53. PubMed ID: 10959309
[No Abstract] [Full Text] [Related]
15. C-reactive protein and coronary heart disease.
Ridker PM; Koenig W; Fuster V
N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257563
[No Abstract] [Full Text] [Related]
16. C-reactive protein--to screen or not to screen?
Mosca L
N Engl J Med; 2002 Nov; 347(20):1615-7. PubMed ID: 12432050
[No Abstract] [Full Text] [Related]
17. Follicular fluid levels of the long pentraxin PTX3.
Paffoni A; Ragni G; Doni A; Somigliana E; Pasqualini F; Restelli L; Pardi G; Mantovani A; Garlanda C
J Soc Gynecol Investig; 2006 Apr; 13(3):226-31. PubMed ID: 16516502
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.
Mauri T; Coppadoro A; Bellani G; Bombino M; Patroniti N; Peri G; Mantovani A; Pesenti A
Crit Care Med; 2008 Aug; 36(8):2302-8. PubMed ID: 18596636
[TBL] [Abstract][Full Text] [Related]
19. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
[TBL] [Abstract][Full Text] [Related]
20. Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD.
Meier P
Clin J Am Soc Nephrol; 2011 Apr; 6(4):697-9. PubMed ID: 21441127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
